Benoit Martineau, President Director at Sanofi Indonesia, explains the transformation of the Indonesian affiliate and reaffirms the strong commitment of Sanofi in helping the Indonesian government to successfully implement their patient access roadmap.
Mr. Martineau, could you please introduce yourself to our international audience as well as your main areas of focus and priorities since your appointment as head of Sanofi’s Indonesia operations in April 2015?
"Even though Sanofi is positioned as the top pharmaceutical MNC in the country, Indonesia is one of the most challenging markets in the SEA region where more than 70 percent of the pharmaceutical value is in the hands of local players and, as a multinational, we need to have very well defined short- as well as long-term strategy to maintain our leadership."
